Liao ZJ - Search Results

1

HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity.

Ding G, Liu HD, Huang Q, Liang HX, Ding ZH, Liao ZJ, Huang G. Ding G, et al. Among authors: liao zj. FEBS Lett. 2013 Apr 2;587(7):880-6. doi: 10.1016/j.febslet.2013.02.001. Epub 2013 Feb 10. FEBS Lett. 2013. PMID: 23402884 Free article.

2

MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.

Hua HW, Jiang F, Huang Q, Liao Z, Ding G. Hua HW, et al. Oncotarget. 2015 Feb 28;6(6):3840-7. doi: 10.18632/oncotarget.2927. Oncotarget. 2015. PMID: 25708809 Free PMC article.

3

Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma.

Hua HW, Jiang F, Huang Q, Liao ZJ, Ding G. Hua HW, et al. Among authors: liao zj. Tumour Biol. 2015 Jan;36(1):303-13. doi: 10.1007/s13277-014-2633-2. Epub 2014 Sep 25. Tumour Biol. 2015. PMID: 25252848

4

CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.

Ding G, Xu W, Liu H, Zhang M, Huang Q, Liao Z. Ding G, et al. Mol Biol Rep. 2013 May;40(5):3483-91. doi: 10.1007/s11033-012-2423-0. Epub 2013 Mar 9. Mol Biol Rep. 2013. PMID: 23475304

5

Development and Testing of an Intelligent Pain Management System (IPMS) on Mobile Phones Through a Randomized Trial Among Chinese Cancer Patients: A New Approach in Cancer Pain Management.

Sun Y, Jiang F, Gu JJ, Wang YK, Hua H, Li J, Cheng Z, Liao Z, Huang Q, Hu W, Ding G. Sun Y, et al. JMIR Mhealth Uhealth. 2017 Jul 25;5(7):e108. doi: 10.2196/mhealth.7178. JMIR Mhealth Uhealth. 2017. PMID: 28743681 Free PMC article.

6

A Novel Nomogram for Predicting the Risk of Short-Term Recurrence After Surgery in Glioma Patients.

Wang T, Zhu C, Zheng S, Liao Z, Chen B, Liao K, Yang X, Zhou Z, Bai Y, Wang Z, Hou Y, Qiu Y, Huang R. Wang T, et al. Front Oncol. 2021 Oct 26;11:740413. doi: 10.3389/fonc.2021.740413. eCollection 2021. Front Oncol. 2021. PMID: 34778058 Free PMC article.

7

A retrospective analysis of the risk factors affecting recurrence time in patients with recurrent glioblastoma.

Huang R, Wang T, Liao Z, Wang Z, Ye M, Zhou D, Xie H, Bai Y, Qiu Y, Liu Y. Huang R, et al. Ann Palliat Med. 2021 May;10(5):5391-5399. doi: 10.21037/apm-21-823. Epub 2021 May 12. Ann Palliat Med. 2021. PMID: 34044551 Free article.

8

Clinical and DCE-CT signs in predicting microvascular invasion in cHCC-ICC.

Liao ZJ, Lu L, Liu YP, Qin GG, Fan CG, Liu YP, Jia NY, Zhang L. Liao ZJ, et al. Cancer Imaging. 2023 Nov 17;23(1):112. doi: 10.1186/s40644-023-00621-3. Cancer Imaging. 2023. PMID: 37978567 Free PMC article.

9

Knockdown of FGFR3 inhibits the proliferation, migration and invasion of intrahepatic cholangiocarcinoma.

Chen YH, Yang SH, Liu LX, Hu S, Wang XJ, Liao ZJ, Huan YF, He K, Zhang XW. Chen YH, et al. Among authors: liao zj. Dig Liver Dis. 2023 Mar;55(3):400-406. doi: 10.1016/j.dld.2022.07.017. Epub 2022 Aug 20. Dig Liver Dis. 2023. PMID: 35999136

10

EIF5A2 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells.

Yang SH, Hu S, Kang Q, Liu LX, Wei Q, Song ZM, Chen YH, Liao ZJ, Huan YF, Wang XJ, Zou H, Zhang XW. Yang SH, et al. Among authors: liao zj. Clin Res Hepatol Gastroenterol. 2022 Aug-Sep;46(7):101991. doi: 10.1016/j.clinre.2022.101991. Epub 2022 Jul 2. Clin Res Hepatol Gastroenterol. 2022. PMID: 35792239 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page